Acute kidney disease and acute kidney injury biomarkers in coronary care unit patients
UC is characterized by frequent bloody diarrhea, pain, fatigue, and progression, and more than 1/3 of patients require hospitalization or surgery
The effervescent format isnt just about convenience
PBMs have responded to gene therapies through a combination of prior authorization requirements (which serve as the primary utilization management tool), outcomes-based payment arrangements with manufacturers, and in some cases, carve-out arrangements where gene therapy coverage is managed separately from the standard pharmacy benefit
Liver biopsy evaluation in MASH drug development: think thrice, act wise
Epidemiological studies indicated that herbal medicines, by reduction of inflammation, oxidative stress, and neuronal damage, could be a promising strategy to treat MS